COVID-19 vaccine effectiveness against in-hospital mortality in immunocompromised older adults: a Brazilian hospital surveillance study, 2024
Authors:
- Rodrigo Poubel Vieira de RezendeRRRodrigo Poubel Vieira de Rezende
- João Felipe Nicolaci PimentelJPJoão Felipe Nicolaci Pimentel
- Bruno Santos CaxiasBCBruno Santos Caxias
- Caio Moreira SalgueiroCSCaio Moreira Salgueiro
- Lucas Tanikawa de OliveiraLOLucas Tanikawa de Oliveira
- Luís Fernando de Araújo SantosLSLuís Fernando de Araújo Santos
- Caroline Pimentel PessanhaCPCaroline Pimentel Pessanha
- Vitoria Xavier TracierraVTVitoria Xavier Tracierra
- Michael Gunter SimãoMSMichael Gunter Simão
- Mario Gustavo de Aranda PachecoMPMario Gustavo de Aranda Pacheco
- Vitor Alves CruzVCVitor Alves Cruz
- Luiz Eduardo da Costa OliveiraLOLuiz Eduardo da Costa Oliveira
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 29
Abstract
Objective: The study evaluated the association between COVID-19 vaccination and in-hospital mortality among immunocompromised older adults hospitalized for COVID-19 in Brazil during the 2024 epidemiologic year. Methods: This retrospective hospital-based surveillance study used data from the Brazilian SIVEP-Gripe database. All hospitalized cases of COVID-19-related severe acute respiratory syndrome in immunocompromised individuals aged ≥60 years reported during epidemiological weeks 1–52 of 2024 were included. Multivariable logistic regression was used to estimate odds ratio (OR) and 95% confidence interval (95%CI) for the association between COVID-19 vaccination (number of doses) and in-hospital mortality, adjusting for clinical and sociodemographic covariates. Results: Among 474 patients, in-hospital mortality was 36% (171/474). Only 56 (12%) were unvaccinated. Compared with unvaccinated individuals, adjusted ORs for mortality were 0.67 (95%CI 0.32–1.39) for 1–2 doses, 0.67 (95%CI 0.31–1.42) for 3 doses, 0.54 (95%CI 0.26–1.15) for 4 doses, and 0.56 (95%CI 0.26–1.17) for 5–6 doses. Mechanical ventilation (OR 12.55; 95%CI 6.39–26.33) and lower educational attainment (elementary education: OR 2.94; 95%CI 1.39–6.44) were independent predictors of death. COVID-19 vaccination was not significantly associated with reduced in-hospital mortality among immunocompromised older adults hospitalized for the disease in Brazil in 2024. However, all adjusted ORs were below unity, suggesting a trend toward protection with increasing doses. Conclusions: The strong association of mortality with mechanical ventilation and social determinants highlights the need for timely boosters and comprehensive preventive strategies for this vulnerable population.Keywords
This publication has 6 references indexed in Scilit:
- Uptake, effectiveness and safety of COVID-19 vaccines in individuals at clinical risk due to immunosuppressive drug therapy or transplantation procedures: a population-based cohort study in EnglandBMC Medicine, 2024
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5Arthritis & Rheumatology, 2022
- Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 — COVID-NET, 10 States, March 2020–February 2022MMWR. Morbidity and Mortality Weekly Report, 2022
- EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 updateAnnals of the Rheumatic Diseases, 2022
- Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task forceAdvances in Rheumatology, 2022
- Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)Clinical Infectious Diseases, 2020